» Articles » PMID: 30648316

Machine Learning-based Prediction of Future Breast Cancer Using Algorithmically Measured Background Parenchymal Enhancement on High-risk Screening MRI

Overview
Date 2019 Jan 17
PMID 30648316
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Preliminary work has demonstrated that background parenchymal enhancement (BPE) assessed by radiologists is predictive of future breast cancer in women undergoing high-risk screening MRI. Algorithmically assessed measures of BPE offer a more precise and reproducible means of measuring BPE than human readers and thus might improve the predictive performance of future cancer development.

Purpose: To determine if algorithmically extracted imaging features of BPE on screening breast MRI in high-risk women are associated with subsequent development of cancer.

Study Type: Case-control study.

Population: In all, 133 women at high risk for developing breast cancer; 46 of these patients developed breast cancer subsequently over a follow-up period of 2 years.

Field Strength/sequence: 5 T or 3.0 T T -weighted precontrast fat-saturated and nonfat-saturated sequences and postcontrast nonfat-saturated sequences.

Assessment: Automatic features of BPE were extracted with a computer algorithm. Subjective BPE scores from five breast radiologists (blinded to clinical outcomes) were also available.

Statistical Tests: Leave-one-out crossvalidation for a multivariate logistic regression model developed using the automatic features and receiver operating characteristic (ROC) analysis were performed to calculate the area under the curve (AUC). Comparison of automatic features and subjective features was performed using a generalized regression model and the P-value was obtained. Odds ratios for automatic and subjective features were compared.

Results: The multivariate model discriminated patients who developed cancer from the patients who did not, with an AUC of 0.70 (95% confidence interval: 0.60-0.79, P < 0.001). The imaging features remained independently predictive of subsequent development of cancer (P < 0.003) when compared with the subjective BPE assessment of the readers.

Data Conclusion: Automatically extracted BPE measurements may potentially be used to further stratify risk in patients undergoing high-risk screening MRI.

Level Of Evidence: 3 Technical Efficacy: Stage 5 J. Magn. Reson. Imaging 2019;50:456-464.

Citing Articles

Machine Learning Assessment of Background Parenchymal Enhancement in Breast Cancer and Clinical Applications: A Literature Review.

Duong K, Rubner R, Siegel A, Adam R, Ha R, Maldjian T Cancers (Basel). 2024; 16(21).

PMID: 39518120 PMC: 11545443. DOI: 10.3390/cancers16213681.


Development of an MRI Radiomic Machine-Learning Model to Predict Triple-Negative Breast Cancer Based on Fibroglandular Tissue of the Contralateral Unaffected Breast in Breast Cancer Patients.

Gullo R, Ochoa-Albiztegui R, Chakraborty J, Thakur S, Robson M, Jochelson M Cancers (Basel). 2024; 16(20).

PMID: 39456574 PMC: 11506272. DOI: 10.3390/cancers16203480.


New Frontiers in Breast Cancer Imaging: The Rise of AI.

Shamir S, Sasson A, Margolies L, Mendelson D Bioengineering (Basel). 2024; 11(5).

PMID: 38790318 PMC: 11117903. DOI: 10.3390/bioengineering11050451.


Computerized assessment of background parenchymal enhancement on breast dynamic contrast-enhanced-MRI including electronic lesion removal.

Douglas L, Fuhrman J, Hu Q, Edwards A, Sheth D, Abe H J Med Imaging (Bellingham). 2024; 11(3):034501.

PMID: 38737493 PMC: 11086664. DOI: 10.1117/1.JMI.11.3.034501.


Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.

Yan R, Murakami W, Mortazavi S, Yu T, Chu F, Lee-Felker S Eur Radiol. 2024; 34(10):6358-6368.

PMID: 38683385 PMC: 11399191. DOI: 10.1007/s00330-024-10758-9.


References
1.
Jansen S, Lin V, Giger M, Li H, Karczmar G, Newstead G . Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol. 2011; 21(7):1374-82. DOI: 10.1007/s00330-011-2080-z. View

2.
Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen C . Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997; 203(1):145-9. DOI: 10.1148/radiology.203.1.9122383. View

3.
King V, Brooks J, Bernstein J, Reiner A, Pike M, Morris E . Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology. 2011; 260(1):50-60. PMC: 6939979. DOI: 10.1148/radiol.11102156. View

4.
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J . pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011; 12:77. PMC: 3068975. DOI: 10.1186/1471-2105-12-77. View

5.
Siegel R, Miller K, Jemal A . Cancer statistics, 2016. CA Cancer J Clin. 2016; 66(1):7-30. DOI: 10.3322/caac.21332. View